blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3921441

EP3921441 - A METHOD FOR DETERMINING THE SEVERITY OR GRADE OF HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIA [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  06.06.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  12.11.2021
FormerThe international publication has been made
Status updated on  14.08.2020
Formerunknown
Status updated on  11.02.2020
Most recent event   Tooltip07.06.2024First examination report 
Applicant(s)For all designated states
Charité - Universitätsmedizin Berlin
Charitéplatz 1
10117 Berlin / DE
[2021/50]
Inventor(s)01 / KAUFMANN, Andreas
Lörracherstraße 2a
12247 Berlin / DE
[N/P]
Former [2021/50]01 / KAUFMANN, Andreas
12247 Berlin / DE
Representative(s)Hertin und Partner Rechts- und Patentanwälte PartG mbB
Kurfürstendamm 54/55
10707 Berlin / DE
[2021/50]
Application number, filing date20702670.907.02.2020
[2021/50]
WO2020EP53095
Priority number, dateEP2019015620308.02.2019         Original published format: EP 19156203
[2021/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020161285
Date:13.08.2020
Language:EN
[2020/33]
Type: A1 Application with search report 
No.:EP3921441
Date:15.12.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 13.08.2020 takes the place of the publication of the European patent application.
[2021/50]
Search report(s)International search report - published on:EP13.08.2020
ClassificationIPC:C12Q1/6886, C12Q1/70
[2021/50]
CPC:
C12Q1/6886 (EP,US); C12Q1/708 (EP,US); C12Q2600/112 (EP,US);
C12Q2600/158 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/50]
TitleGerman:VERFAHREN ZUR BESTIMMUNG DES SCHWEREGRADES VON DURCH DAS HUMANE PAPILLOMAVIRUS (HPV) INDUZIERTER DYSPLASIE[2021/50]
English:A METHOD FOR DETERMINING THE SEVERITY OR GRADE OF HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIA[2021/50]
French:PROCÉDÉ POUR DÉTERMINER LA GRAVITÉ OU LE DEGRÉ DE DYSPLASIE INDUITE PAR LE PAPILLOMAVIRUS HUMAIN (PVH)[2021/50]
Entry into regional phase23.08.2021National basic fee paid 
23.08.2021Designation fee(s) paid 
23.08.2021Examination fee paid 
Examination procedure23.08.2021Examination requested  [2021/50]
23.08.2021Date on which the examining division has become responsible
22.03.2022Amendment by applicant (claims and/or description)
05.06.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
17.02.2022Renewal fee patent year 03
15.02.2023Renewal fee patent year 04
23.02.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP1369694  (MTM LAB AG [DE]);
 [I]US2004202996  (WILLIAMS INNA R [US], et al);
 [A]US2017204481  (RABBANI ELAZAR [US], et al);
by applicantUS2004202996
 US2017204481
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.